News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Blood test detects when hormone treatment for breast cancer stops working
Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further treatment.
New genetic cause of a childhood kidney cancer discovered
Genetic mutations in a gene called REST have been shown to cause Wilms tumour, a rare kidney cancer that occurs in children.
Blood test picks out prostate cancer drug resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Changes urged to radiotherapy practice that could save NHS tens of millions per year
Major clinical trial finds new regime for prostate cancer at least as good, cheaper and more convenient than current practice
Professor Mel Greaves wins Cancer Research UK Lifetime Achievement Award
The ICR’s Professor Mel Greaves has been awarded the Cancer Research UK Lifetime Achievement Award for his work investigating the causes and clonal evolution of childhood leukaemia.
Landmark clinical trial shows gene-targeted drug can treat prostate cancer
First trial to show benefit of ‘precision medicine’ in prostate cancer
Genetic testing could identify men at a 10-fold increased risk of testicular cancer
A new study of more than 25,000 men has uncovered four new genetic variants associated with increased risk of testicular cancer.
Chemical probe to dissect role of potential cancer-causing proteins
Scientists have created a highly specific chemical probe to shed new light on the role two important proteins play in driving cancer cell proliferation.
T-VEC becomes first viral immunotherapy recommended for approval in Europe
A viral immunotherapy for cancer has become the first to be given the green light by European regulators.
Study identifies new treatment target in BRCA2-mutant prostate cancer
Genetic abnormalities associated with poor prognosis in prostate cancer are particularly common in men with germline mutations in the BRCA2 gene.
Test could predict whether breast cancer will spread to the brain
Women with particularly aggressive forms of breast cancer could be identified by a test that predicts whether the disease is likely to spread to the brain.
Another successful year for the ICR team at the Royal Parks Half Marathon
All 24 of our runners in the Royal Parks Half Marathon completed the 13.1 mile course and together are set to raise £25,000 for our research.
